30 related articles for article (PubMed ID: 21624013)
1. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features.
Feng CW; Wang LD; Jiao LH; Liu B; Zheng S; Xie XJ
BMC Cancer; 2002 Apr; 2():8. PubMed ID: 11978184
[TBL] [Abstract][Full Text] [Related]
2. Unveiling the significance of inducible nitric oxide synthase: Its impact on cancer progression and clinical implications.
Chen T
Cancer Lett; 2024 Jun; 592():216931. PubMed ID: 38701892
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the immunohistochemical expression of vascular endothelial growth factors in malignant salivary gland neoplasms: a systematic review and meta-analysis.
Dos Santos E; Ramos JC; Normando AG; Leme AF
Med Oral Patol Oral Cir Bucal; 2021 Mar; 26(2):e126-e135. PubMed ID: 33609023
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors.
Pouloudi D; Sotiriadis A; Theodorakidou M; Sarantis P; Pergaris A; Karamouzis MV; Theocharis S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302367
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of VEGF expression correlates with COX-2 expression in pleomorphic adenoma, mucoepidermoid carcinoma and adenoid cystic carcinoma.
Shamloo N; Taghavi N; Yazdani F; Azimian P; Ahmadi S
Dent Res J (Isfahan); 2020; 17(2):100-106. PubMed ID: 32435431
[TBL] [Abstract][Full Text] [Related]
6. Uncoupling of Vascular Endothelial Growth Factor (VEGF) and Inducible Nitric Oxide Synthase (iNOS) in Gingival Tissue of Type 2 Diabetic Patients.
Lucarini G; Tirabassi G; Zizzi A; Balercia G; Quaranta A; Rubini C; Aspriello SD
Inflammation; 2016 Apr; 39(2):632-42. PubMed ID: 26635115
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of CD34 expression in salivary gland tumors.
Moghadam SA; Abadi AM; Mokhtari S
J Oral Maxillofac Pathol; 2015; 19(1):30-3. PubMed ID: 26097303
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α regulated tongue squamous cell carcinoma cell growth via regulating VEGF expression in a xenograft model.
Liang J; Zhang Z; Liang L; Shen Y; Ouyang K
Ann Transl Med; 2014 Sep; 2(9):92. PubMed ID: 25405167
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase 2 (NOS2) expression in histologically normal margins of oral squamous cell carcinoma.
Morelatto R; Itoiz ME; Guiñazú N; Piccini D; Gea S; López-de Blanc S
Med Oral Patol Oral Cir Bucal; 2014 May; 19(3):e242-7. PubMed ID: 24316703
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of serum vascular endothelial growth factor in patients with salivary gland tumor.
Andisheh Tadbir A; Khademi B; Malekzadeh M; Mardani M; Khademi B
Patholog Res Int; 2013; 2013():740582. PubMed ID: 23984187
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-tumor cell interactions regulate the function of nitric oxide.
Rahat MA; Hemmerlein B
Front Physiol; 2013; 4():144. PubMed ID: 23785333
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of VEGF immunohistochemical expression in oral cancer: a meta-analysis of the literature.
Zhao SF; Yang XD; Lu MX; Sun GW; Wang YX; Zhang YK; Pu YM; Tang EY
Tumour Biol; 2013 Oct; 34(5):3165-71. PubMed ID: 23737289
[TBL] [Abstract][Full Text] [Related]
13. Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome.
Zhang J; Peng B; Chen X
Clin Cancer Res; 2005 Oct; 11(20):7334-43. PubMed ID: 16243805
[TBL] [Abstract][Full Text] [Related]
14. Expression of inducible nitric oxide synthase and vascular endothelial growth factor in ameloblastoma.
Chen WL; Ouyang KX; Li HG; Huang ZQ; Li JS; Wang JG
J Craniofac Surg; 2009 Jan; 20(1):171-5; discussion 176-7. PubMed ID: 19165019
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
[TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase-vascular endothelial growth factor axis: a potential target to inhibit tumor angiogenesis by dietary agents.
Singh RP; Agarwal R
Curr Cancer Drug Targets; 2007 Aug; 7(5):475-83. PubMed ID: 17691907
[TBL] [Abstract][Full Text] [Related]
17. Mucoepidermoid carcinoma of the breast, 3 cases report and literature review.
He X; You J; Chen Y; Tang H; Ran J; Guo D
Medicine (Baltimore); 2023 May; 102(18):e33707. PubMed ID: 37144989
[TBL] [Abstract][Full Text] [Related]
18. Association of clinicopathologic parameters with the expression of inducible nitric oxide synthase and vascular endothelial growth factor in mucoepidermoid carcinoma.
Ou Yang KX; Liang J; Huang ZQ
Oral Dis; 2011 Sep; 17(6):590-6. PubMed ID: 21624013
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
